Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Deals
Biotech
Novartis returns to Argo for $5B cardiovascular collab
Novartis has returned to Argo with $160 million in upfront cash to explore various cardiovascular meds in the Chinese biotech’s siRNA pipeline.
James Waldron
Sep 3, 2025 9:15am
China-based Novatim notches new deal with another US biotech
Sep 2, 2025 2:36pm
Royalty bestows Zenas with $300M for autoimmune approval push
Sep 2, 2025 11:07am
Vertex boosts artillery with $2B-plus Enlaza pact
Sep 2, 2025 10:26am
Novartis aims at alpha-synuclein again with $2.2B Arrowhead deal
Sep 2, 2025 9:55am
Genentech pens $420M deal for Omass' preclinical IBD program
Sep 2, 2025 3:00am
